Nuvation Bio (Nuvation Bio) ROCE % : -11.48% (As of Sep. 2021)

View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nuvation Bio's annualized ROCE % for the quarter that ended in Sep. 2021 was -11.48%.

Nuvation Bio ROCE % Historical Data

The historical data trend for Nuvation Bio's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio ROCE % Chart

Nuvation Bio Annual Data

Trend

Dec20

Dec21

ROCE %

-20.70

Nuvation Bio Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
ROCE %	Get a 7-Day Free Trial			-	-16.99	-10.05	-11.48	-15.34

Nuvation Bio ROCE % Calculation

Nuvation Bio's annualized ROCE % for the fiscal year that ended in Dec. 2020 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2020 )		(A: . 20 )		(A: Dec. 2020 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2020 )		(A: . 20 )		(A: Dec. 2020 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

Nuvation Bio's ROCE % of for the quarter that ended in Sep. 2021 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2021 )		(Q: Jun. 2021 )		(Q: Sep. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2021 )		(Q: Jun. 2021 )		(Q: Sep. 2021 )
	=	-91.164	/	( ( (814.263 - 10.09)	+	(797.791 - 13.308) )	/ 2 )
	=	-91.164	/	( ( 804.173	+	784.483 )	/ 2 )
	=	-91.164	/	794.328
	=	-11.48 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2021) EBIT data.

Nuvation Bio (NYSE:NUVB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nuvation Bio ROCE % Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1500 Broadway, Suite 1401, New York, NY, USA, 10036

Website

https://www.nuvationbio.com

Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.